Please login to the form below

Not currently logged in
Email:
Password:

mergers

This page shows the latest mergers news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

closer to a merger than a takeover, as Shire’s shareholders will take on a 50% stake in the new entity. ... That merger ill-fated, and seen as a high watermark in highly leveraged pharma deal-making with shaky business rationale; some investors fear

Latest news

More from news
Approximately 84 fully matching, plus 425 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 35 partially matching documents found.

Latest appointments

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy, Magovcevic-Liebisch has worked in several management roles including executive vice president and chief

  • IRX Therapeutics appoints Luba Greenwood to its board IRX Therapeutics appoints Luba Greenwood to its board

    Her career has spanned leadership roles in venture investing, business development, mergers and acquisitions, law, consulting and operations. ... Prior to that, she served as senior mergers and acquisitions counsel at Pfizer.

  • Reig Jofre boosts Forté Pharma’s senior team Reig Jofre boosts Forté Pharma’s senior team

    Ignasi Biosca, chief executive officer, Reig Jofre, said: “We had been working for some time on Forté Pharma's development plan after the merger with Natraceutical, and I am convinced that

  • Reig Jofre appoints Alejandro Reig as vice president Reig Jofre appoints Alejandro Reig as vice president

    He most recently took the director position at Reig Jofre after its merger with Natraceutical in December 2015.

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently

More from appointments
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics